Get the content you want anytime you want.

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Merck's Letermovir for CMV Prevention Approved by FDA
Roy F. Chemaly, MD, MPH, discusses the background behind letermovir and what it brings to the table.
Addressing Issues Surrounding Current Antibiotic Development
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
Addressing Challenges Faced by Hospital Epidemiologists
Silvia Munoz-Price, MD, PhD, shares a few issues that hospital epidemiologists currently face.
What Are the Special Properties of MRSA Prodrug TXA709?
Edmond LaVoie, PhD, describes the properties of prodrug TXA709.
How Can We Estimate the Burden of Healthcare-Associated Infections in Nursing Homes?
Nicola Thompson, PhD, shares what is needed to estimate the burden of healthcare-associated infections in nursing homes.
How Effective Are <i>C. difficile</i> Bundled Approaches?
Gonzalo Bearman, MD, MPH, shares a few things to keep in mind when using bundled approaches against C. difficile.
What Are The Drawbacks Of Current Front-Line Drugs to Treat <i>C. difficile</i> Infection?
Kirk Hevener, PharmD, PhD, explains the drawbacks of first-line drugs that are currently used to treat C. difficile infections.
What is the Role of Combination Therapy in Treating <i>S. aureus</i> Infections?
Prof. Josh Davis, MBBS, PhD, discusses the role of combination therapy when it comes to treating invasive Staphylococcus aureus infections.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.